Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Discontinued operation pulls down GeoPharma results
Bizjournals.com
Monday, August 17, 2009 - 9:16am
tags:
GeoPharma, earnings
Unlocking Access Pharma's Value: Key Upcoming Catalysts
Seeking Alpha
Monday, August 17, 2009 - 9:13am
tags:
Access Pharmaceuticals
FDA grants temporary approval for Protalix drug
Marketwatch
Monday, August 17, 2009 - 9:11am
tags:
FDA, Protalix BioTherapeutics, Gaucher disease, Genzyme, Cerezyme
Health Reform Update: Good-Bye Public Option. Hello, Co-Ops!
WSJ Online
Monday, August 17, 2009 - 9:10am
tags:
healthcare reform, insurance co-ops
Sanofi Says Court Stops Approval of Eloxatin Copies
Bloomberg
Monday, August 17, 2009 - 9:09am
tags:
Sanofi, Eloxatin, generics, patents, cancer
Novartis gets FDA approval for MS drug
Marketwatch
Monday, August 17, 2009 - 9:08am
tags:
Novartis, FDA, MS, multiple sclerosis, Extavia
Tinayin Pharma Adds Two New Products to TCM Portfolio
Seeking Alpha
Sunday, August 16, 2009 - 11:06am
tags:
Tianyin Pharmaceutical
China Biotech in Review: The Business of China Life Science
Seeking Alpha
Sunday, August 16, 2009 - 11:05am
tags:
China
Novartis sues Glaxo Smith Kline over vaccine patent
Times Online, UK
Sunday, August 16, 2009 - 10:29am
tags:
GSK, Novartis
Study: 50% of Americans want H1N1 vaccine
FoodConsumer
Sunday, August 16, 2009 - 10:28am
tags:
H1N1
Two Life Science Companies Manage to Pry Open IPO Window
Seeking Alpha
Sunday, August 16, 2009 - 9:55am
tags:
Cumberland, Emdeon
Glancy Binkow & Goldberg LLP, Representing Investors Who Purchased Repros Therapeutics Inc., Announces Class Action Lawsuit and Seeks to Recover Losses
Yahoo/BusinessWire
Saturday, August 15, 2009 - 11:33am
tags:
Repros Therapeutics, Proellex
Ranbaxy launches protein supplement
webnewswire.com
Saturday, August 15, 2009 - 11:31am
tags:
Ranbaxy
Akela Pharma reports results for the second quarter of fiscal 2009
CNW Telbec
Saturday, August 15, 2009 - 11:27am
tags:
Akela Pharma
BioSante Pharmaceuticals Closes $12 Million Registered Direct Offering
BusinessWire
Saturday, August 15, 2009 - 11:16am
tags:
BioSante
BioPharm Asia Reports Strong Growth in Revenues, Income for Second Quarter of 2009
Fox Business
Saturday, August 15, 2009 - 11:15am
tags:
Biopharm Asia
Berkshire reports Becton Dickinson stake, ups J&J
Reuters
Saturday, August 15, 2009 - 11:03am
tags:
JNJ, Becton Dickinson
Amgen Close to Scoring Big
Motley Fool
Saturday, August 15, 2009 - 11:02am
tags:
Amgen, denosumab
Gilead Sciences Receives Subpoena from U.S. Department of Health & Human Services Regarding Ranexa
Yahoo/BusinessWire
Saturday, August 15, 2009 - 10:39am
tags:
Gilead Sciences, Ranexa
Hana Biosciences Announces Second Quarter 2009 Results
Yahoo/GlobalNewsWire
Saturday, August 15, 2009 - 10:37am
tags:
Hana Biosciences

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.